Key result
Delivery of a small-for-gestational-age neonate was associated with lower postpartum flow-mediated dilatation compared to delivery of an appropriately grown baby (6.79% vs 10.26%; P=0.0007).
Why the study?
Does delivery of a small-for-gestational-age neonate associate with impaired maternal endothelial function postpartum?
Case-Control (n=44)
No
Does delivery of a small-for-gestational-age neonate associate with impaired maternal endothelial function postpartum?
Mean Difference: -3.47 (95% CI -5.37–-1.57)
Absolute Event Rate: 6.79% vs 10.26%
p-value: p=0.0007
Women who deliver a small-for-gestational-age neonate exhibit subclinical endothelial dysfunction within 6 months postpartum, highlighting a potential early window for cardiovascular prevention.
May signal early CVD risk warranting surveillance after SGA; leaves open whether targeted screening improves outcomes.
OBJECTIVE: Women who have delivered a small-for-gestational-age (SGA) infant are at an increased risk of developing cardiovascular disease (CVD) in later life. Endothelial dysfunction is a subclinical sign of early CVD. It is unknown whether women who have recently had a pregnancy complicated by SGA, in the absence of other maternal and fetal diseases, have subclinical endothelial dysfunction. Our aim was to assess maternal endothelial function 6 months after a pregnancy complicated by SGA. METHODS: This was a case-control study conducted in a tertiary referral hospital in London, UK, over a 15-month period. Flow-mediated dilatation (FMD) of the brachial artery was measured in women 6.9 ± 2.5 months after childbirth. Forty-four women were included in the study, of whom 15 had a SGA neonate (mean ± SD customized birth centile of 1.9 ± 2.3) and 29 delivered an appropriately grown baby (mean ± SD customized birth centile of 47.5 ± 26.3). The primary continuous variable, FMD, was assessed in each group and compared using unpaired t-test. RESULTS: Women who had a SGA neonate had lower postpartum FMD (6.79 ± 0.95%) than did those who had an appropriately grown offspring (10.26 ± 2.44% (95% CI for difference between groups, -5.37 to -1.57); P = 0.0007). There were no differences in postnatal maternal blood pressure, abdominal circumference, weight and glucose, insulin and lipid profiles between the two groups. CONCLUSIONS: Women who had a pregnancy affected by SGA, probably due to placental failure in the absence of pre-eclampsia, have evidence of subclinical endothelial dysfunction within 6 months of childbirth. These women may benefit from lifestyle measures focused on the primary prevention of CVD. Further research in larger populations is needed to ascertain if such postpartum maternal endothelial dysfunction is a pregnancy-induced phenomenon or if it is related to the pre-existing maternal phenotype, and whether it persists long term.
No takes yet. Share an insight, caveat, or question.
Hillman et al. (2017) conducted a case-control in Small-for-gestational-age pregnancy (n=44). Delivery of a small-for-gestational-age neonate vs. Delivery of an appropriately grown baby was evaluated on Flow-mediated dilatation (FMD) of the brachial artery (MD -3.47, 95% CI -5.37 to -1.57, p=0.0007). Delivery of a small-for-gestational-age neonate was associated with lower postpartum flow-mediated dilatation compared to delivery of an appropriately grown baby (6.79% vs 10.26%; P=0.0007).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: